CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion | +2,063 | $5.95 | $12K | 3,170 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −109 | $219.55 | $24K | 3,061 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −168 | $220.33 | $37K | 2,893 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −250 | $221.32 | $55K | 2,643 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −227 | $222.39 | $50K | 2,416 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −188 | $223.48 | $42K | 2,228 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −120 | $224.93 | $27K | 2,108 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −248 | $225.45 | $56K | 1,860 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −538 | $226.59 | $122K | 1,322 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −569 | $227.82 | $130K | 753 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −369 | $228.64 | $84K | 384 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −38 | $230.04 | $9K | 346 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −59 | $231.40 | $14K | 287 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Sale | −12 | $232.35 | $3K | 275 |
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −416 | 4,176 | ||
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −416 | 9,175 | ||
| 2021-02-26 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,063 | 63,938 | ||
| 2021-02-18 | Glenn Gregory M President, R&D | Sale | −80 | $264.09 | $21K | 5,165 |
| 2021-02-18 | Glenn Gregory M President, R&D | Sale | −361 | $265.52 | $96K | 4,804 |
| 2021-02-18 | Glenn Gregory M President, R&D | Sale | −128 | $266.68 | $34K | 4,676 |
Page 68 of 87 · 1,734 trades